Advertisement

International Urology and Nephrology

, Volume 50, Issue 5, pp 963–971 | Cite as

Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters

  • John J. Sim
  • Hui Zhou
  • Jiaxiao Shi
  • Sally F. Shaw
  • Shayna L. Henry
  • Csaba P. Kovesdy
  • Kamyar Kalantar-Zadeh
  • Steven J. Jacobsen
Nephrology - Original Paper

Abstract

Purpose

The early period after chronic kidney disease (CKD) patients transition to end-stage renal disease (ESRD) represents the highest mortality risk but is variable among different patient populations and clinical circumstances. We compared early mortality outcomes among a diverse CKD population that transitioned to ESRD.

Methods

A retrospective cohort study (1/1/2002 through 12/31/2013) of CKD patients (age ≥ 18 years) who transitioned to peritoneal dialysis (PD), hemodialysis (HD) with arteriovenous fistula/grafts, and HD with catheters was performed. Multivariable Cox regression modeling was used to estimate 6-month all-cause mortality hazard ratios (HR) among the three treatment groups after adjustment for patient and clinical characteristics.

Results

Among 5373 ESRD patients (62.7 years, 41.3% females, 37.5% Hispanics, 13.3% PD, 34.9% HD with fistula/graft, 51.8% HD with catheter), 551 (10.3%) died at 6 months. Mortality rates were highest immediately after transition (299 deaths per 1000 person-years in first month). Compared to PD patients, the 6-month mortality HR (95% CI) was 1.87 (1.06–3.30) in HD with fistula/graft patients and 3.77 (2.17–6.57) in HD with catheter patients. Inpatient transition (HR 1.32), acute kidney injury (HR 2.06), and an eGFR ≥ 15 vs 5–9 (HR 1.68) at transition were also associated with higher early mortality risk.

Conclusion

Among a diverse CKD population who transitioned to ESRD, we observed considerable differences in early mortality risk among PD, HD with fistula/graft, and HD with catheter patients. The identification of patient-specific and clinical environmental factors related to high early mortality may provide insights for managing advanced stages of CKD and shared decision making.

Keywords

Mortality End-stage renal disease transition Chronic kidney disease Epidemiology Comparative outcomes 

Notes

Acknowledgement

The authors would like to thank Joanie Chung and David Yi for their work on programming and data extraction for this study. The authors also would like to thank Jose Pio for his literature support and administrative assistance on this study. Finally, we would like to thank and acknowledge the members and patients of KPSC who are the source for our findings and the foundation for why we perform research at KPSC. The results presented in this paper have not been published previously in whole or part, except in abstract format.

Author contributions

JJS and SJJ contributed to research area and study design; HZ and JS were involved in data acquisition; JJS, SJJ, HZ, JS, KKZ, and CPK participated in analysis or interpretation of data; JJS and SJJ were involved in study supervision; HZ was involved in statistical analysis; JJS drafted the manuscript; SJJ, HZ, SFS, KKZ, CPK, SH, and JS were involved in critical revision of the manuscript for important intellectual content; SFS and SJJ participated in administrative, technical, or material support. Each author contributed important intellectual content during the manuscript drafting or revision and accepts accountability of the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. JJS takes responsibility that this study has been reported honestly, accurately, and transparently; that no important aspects of the study have been omitted, and that any discrepancies from the study as planned have been explained.

Funding

This study was funded by 5U01DK102163 from the National Institute of Health (NIH) to CPK and KKZ. This study was also supported by the Kaiser Permanente Southern California Clinician Investigator Award (JJS).

Compliance with ethical standards

Conflict of interest

All author declares that they have no conflict of interest

Supplementary material

11255_2018_1837_MOESM1_ESM.docx (16 kb)
Supplementary material 1 (DOCX 15 kb)

References

  1. 1.
    Saran R, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, Han Y, He K, Herman W, Heung M, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Li Y, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O’Hare AM, Obi Y, Plattner B, Pisoni R, Port FK, Rao P, Ravel V, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA, Shahinian V (2017) US renal data system 2016 Annual data report: epidemiology of kidney disease in the United States. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 69 (3S1):A7–A8. https://doi.org/10.1053/j.ajkd.2016.12.004Google Scholar
  2. 2.
    Foley RN, Chen SC, Solid CA, Gilbertson DT, Collins AJ (2014) Early mortality in patients starting dialysis appears to go unregistered. Kidney Int 86(2):392–398.  https://doi.org/10.1038/ki.2014.15 CrossRefPubMedGoogle Scholar
  3. 3.
    Chan KE, Maddux FW, Tolkoff-Rubin N, Karumanchi SA, Thadhani R, Hakim RM (2011) Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol 6(11):2642–2649.  https://doi.org/10.2215/CJN.03680411 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Robinson BM, Zhang J, Morgenstern H, Bradbury BD, Ng LJ, McCullough KP, Gillespie BW, Hakim R, Rayner H, Fort J, Akizawa T, Tentori F, Pisoni RL (2014) Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 85(1):158–165.  https://doi.org/10.1038/ki.2013.252 CrossRefPubMedGoogle Scholar
  5. 5.
    Sladoje-Martinovic B, Mikolasevic I, Bubic I, Racki S, Orlic L (2014) Survival of chronic hemodialysis patients over 80 years of age. Clin Interv Aging 9:689–696.  https://doi.org/10.2147/CIA.S58976 PubMedPubMedCentralGoogle Scholar
  6. 6.
    Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW (2007) Predictors of early mortality among incident US hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol 2(1):89–99.  https://doi.org/10.2215/cjn.01170905 CrossRefPubMedGoogle Scholar
  7. 7.
    Hwang SJ, Yang WC, Lin MY, Mau LW, Chen HC, Taiwan Society of N (2010) Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan. In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association–European Renal Association 25 (8):2616–2624.  https://doi.org/10.1093/ndt/gfq308
  8. 8.
    Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K (2012) Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol 35 (6):548–558.  https://doi.org/10.1159/000338673
  9. 9.
    Wick JP, Turin TC, Faris PD, MacRae JM, Weaver RG, Tonelli M, Manns BJ, Hemmelgarn BR (2016) A clinical risk prediction tool for 6-month mortality after dialysis initiation among older adults. Am J Kidney Dis.  https://doi.org/10.1053/j.ajkd.2016.08.035 PubMedGoogle Scholar
  10. 10.
  11. 11.
    USRDS https://www.usrds.org/2016/view/v1_08.aspx. Accessed 30 Jan 2017
  12. 12.
    Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI (2009) Chronic Renal Insufficiency Cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 4(8):1302–1311.  https://doi.org/10.2215/CJN.00070109 CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Mariani L, Stengel B, Combe C, Massy ZA, Reichel H, Fliser D, Pecoits-Filho R, Lopes AA, Yamagata K, Wada T, Wong MM, Speyer E, Port FK, Pisoni RL, Robinson BM (2016) The CKD outcomes and practice patterns study (CKDopps): rationale and methods. Am J Kidney Dis 68(3):402–413.  https://doi.org/10.1053/j.ajkd.2016.03.414 CrossRefPubMedGoogle Scholar
  14. 14.
    Kalantar-Zadeh K, Kovesdy CP, Streja E, Rhee CM, Soohoo M, Chen JL, Molnar MZ, Obi Y, Gillen D, Nguyen DV, Norris KC, Sim JJ, Jacobsen SS (2017) Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Trans Off Pub Eur Dial Trans Assoc Eur Renal Assoc.  https://doi.org/10.1093/ndt/gfw357 Google Scholar
  15. 15.
    Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17–28.  https://doi.org/10.1038/ki.2010.483 CrossRefPubMedGoogle Scholar
  16. 16.
    Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI (2009) A new equation to estimate glomerular filtration rate. Ann Int Med 150(9):604–612CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P (2009) Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am J Kidney Dis Off J Natl Kidney Found 53(3 Suppl 3):S86–99.  https://doi.org/10.1053/j.ajkd.2008.07.052 CrossRefGoogle Scholar
  18. 18.
    Rivara MB, Chen CH, Nair A, Cobb D, Himmelfarb J, Mehrotra R (2016) Indication for dialysis initiation and mortality in patients with chronic kidney failure: a retrospective cohort study. Am J Kidney Dis Off J Natl Kidney Found.  https://doi.org/10.1053/j.ajkd.2016.06.024 Google Scholar
  19. 19.
    Naimark DM, Grams ME, Matsushita K, Black C, Drion I, Fox CS, Inker LA, Ishani A, Jee SH, Kitamura A, Lee JP, Nally J, Peralta CA, Rothenbacher D, Ryu S, Tonelli M, Coresh J, Gansevoort RT, Yatsuya H, Warnock DG, Woodward M, de Jong PE, Consortium CKDP (2016) Past decline versus current eGFR and subsequent mortality risk. J Am Soc Nephrol JASN 27(8):2456–2466.  https://doi.org/10.1681/ASN.2015060688 CrossRefPubMedGoogle Scholar
  20. 20.
    Xue JL, Dahl D, Ebben JP, Collins AJ (2003) The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis Off J Natl Kidney Found 42(5):1013–1019CrossRefGoogle Scholar
  21. 21.
    Fischer MJ, Stroupe KT, Kaufman JS, O’Hare AM, Browning MM, Sohn MW, Huo Z, Hynes DM (2016) Predialysis nephrology care and dialysis-related health outcomes among older adults initiating dialysis. BMC Nephrol 17(1):103.  https://doi.org/10.1186/s12882-016-0324-5 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA (2010) A randomized, controlled trial of early versus late initiation of dialysis. N England J Med 363(7):609–619.  https://doi.org/10.1056/NEJMoa1000552 CrossRefGoogle Scholar
  23. 23.
    Yamagata K, Nakai S, Iseki K, Tsubakihara Y (2012) Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] dialysis therapy registry. Therapeutic Apheresis Dial 16(2):111–120.  https://doi.org/10.1111/j.1744-9987.2011.01052.x CrossRefGoogle Scholar
  24. 24.
    Wright S, Klausner D, Baird B, Williams ME, Steinman T, Tang H, Ragasa R, Goldfarb-Rumyantzev AS (2010) Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol CJASN 5(10):1828–1835.  https://doi.org/10.2215/CJN.06230909 CrossRefPubMedGoogle Scholar
  25. 25.
    Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK (2001) Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 60(4):1443–1451.  https://doi.org/10.1046/j.1523-1755.2001.00947.x CrossRefPubMedGoogle Scholar
  26. 26.
    Moist LM, Trpeski L, Na Y, Lok CE (2008) Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian organ replacement registry 2001–2004. Clin J Am Soc Nephrol 3(6):1726–1732.  https://doi.org/10.2215/cjn.01240308 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler JH, Kliger A, Powe NR (2005) Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Int Med 143(3):174–183CrossRefPubMedGoogle Scholar
  28. 28.
    Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG (2003) Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol JASN 14(2):415–424CrossRefPubMedGoogle Scholar
  29. 29.
    Vonesh EF, Snyder JJ, Foley RN, Collins AJ (2004) The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 66(6):2389–2401.  https://doi.org/10.1111/j.1523-1755.2004.66028.x CrossRefPubMedGoogle Scholar
  30. 30.
    Thamer M, Kaufman JS, Zhang Y, Zhang Q, Cotter DJ, Bang H (2015) Predicting early death among elderly dialysis patients: development and validation of a risk score to assist shared decision making for dialysis initiation. Am J Kidney Dis Off J Natl Kidney Found 66 (6):1024–1032.  https://doi.org/10.1053/j.ajkd.2015.05.014
  31. 31.
    Verberne WR, Geers AB, Jellema WT, Vincent HH, van Delden JJ, Bos WJ (2016) Comparative survival among older adults with advanced kidney disease managed conservatively versus with dialysis. Clin J Am Soc Nephrol 11(4):633–640.  https://doi.org/10.2215/CJN.07510715 CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Foote C, Ninomiya T, Gallagher M, Perkovic V, Cass A, McDonald SP, Jardine M (2012) Survival of elderly dialysis patients is predicted by both patient and practice characteristics. Nephrol Dial Transp 27(9):3581–3587.  https://doi.org/10.1093/ndt/gfs096 CrossRefGoogle Scholar
  33. 33.
    Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260–272.  https://doi.org/10.1016/S0140-6736(13)60687-X CrossRefPubMedGoogle Scholar
  34. 34.
    Sim JJ, Rutkowski MP, Selevan DC, Batech M, Timmins R, Slezak JM, Jacobsen SJ, Kanter MH (2015) Kaiser permanente creatinine safety program: a mechanism to ensure widespread detection and care for chronic kidney disease. Am J Med 128 (11):1204–1211.  https://doi.org/10.1016/j.amjmed.2015.05.037
  35. 35.
    Sim JJ, Handler J, Jacobsen SJ, Kanter MH (2014) Systemic implementation strategies to improve hypertension: the Kaiser permanente southern California experience. Can J Cardiol 30 (5):544–552.  https://doi.org/10.1016/j.cjca.2014.01.003
  36. 36.
    Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, Wheeler DC, de Francisco AL, Marcelli D, Froissart M, Floege J, Committee AROS (2015) High cardiovascular event rates occur within the first weeks of starting hemodialysis. Kidney Int 88(5):1117–1125.  https://doi.org/10.1038/ki.2015.117 CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, Levey AS, Hemodialysis Study G (2002) Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. In: The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. American journal of kidney diseases: the official journal of the National Kidney Foundation 39 (1):146–153Google Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • John J. Sim
    • 1
  • Hui Zhou
    • 2
  • Jiaxiao Shi
    • 2
  • Sally F. Shaw
    • 2
  • Shayna L. Henry
    • 2
  • Csaba P. Kovesdy
    • 3
  • Kamyar Kalantar-Zadeh
    • 4
  • Steven J. Jacobsen
    • 2
  1. 1.Division of Nephrology and HypertensionKaiser Permanente Los Angeles Medical CenterLos AngelesUSA
  2. 2.Department of Research and EvaluationKaiser Permanente Southern CaliforniaPasadenaUSA
  3. 3.Division of NephrologyUniversity of Tennessee Health Science CenterMemphisUSA
  4. 4.Division of Nephrology and HypertensionUniversity of California Irvine Medical CenterIrvineUSA

Personalised recommendations